[HTML][HTML] Novel engineered B lymphocytes targeting islet-specific T cells inhibit the development of type 1 diabetes in non-obese diabetic Scid mice
D Chen, D Kakabadse, S Fishman… - Frontiers in …, 2023 - frontiersin.org
Introduction In this study, we report a novel therapeutic approach using B lymphocytes to
attract islet-specific T cells in the non-obese diabetic (NOD) mouse model and prevent the …
attract islet-specific T cells in the non-obese diabetic (NOD) mouse model and prevent the …
[PDF][PDF] Novel engineered B lymphocytes targeting islet-specific T cells inhibit the development of type 1 diabetes in non-obese diabetic Scid mice
D Chen, D Kakabadse, S Fishman, H Weinstein-Marom… - 2023 - pdfs.semanticscholar.org
Methods: Purified splenic B cells were treated with lipopolysaccharide, which increases
regulatory B (Breg) cell function, then electroporated with mRNA encoding either chimeric …
regulatory B (Breg) cell function, then electroporated with mRNA encoding either chimeric …
[HTML][HTML] Novel engineered B lymphocytes targeting islet-specific T cells inhibit the development of type 1 diabetes in non-obese diabetic Scid mice
D Chen, D Kakabadse, S Fishman… - Frontiers in …, 2023 - ncbi.nlm.nih.gov
Methods Purified splenic B cells were treated with lipopolysaccharide, which increases
regulatory B (Breg) cell function, then electroporated with mRNA encoding either chimeric …
regulatory B (Breg) cell function, then electroporated with mRNA encoding either chimeric …
Novel engineered B lymphocytes targeting islet-specific T cells inhibit the development of type 1 diabetes in non-obese diabetic Scid mice
D Chen, D Kakabadse, S Fishman… - Frontiers in …, 2023 - orca.cardiff.ac.uk
Introduction: In this study, we report a novel therapeutic approach using B lymphocytes to
attract islet-specific T cells in the non-obese diabetic (NOD) mouse model and prevent the …
attract islet-specific T cells in the non-obese diabetic (NOD) mouse model and prevent the …
Novel engineered B lymphocytes targeting islet-specific T cells inhibit the development of type 1 diabetes in non-obese diabetic Scid mice
D Chen, D Kakabadse, S Fishman… - Frontiers in …, 2023 - europepmc.org
Methods Purified splenic B cells were treated with lipopolysaccharide, which increases
regulatory B (Breg) cell function, then electroporated with mRNA encoding either chimeric …
regulatory B (Breg) cell function, then electroporated with mRNA encoding either chimeric …
Novel engineered B lymphocytes targeting islet-specific T cells inhibit the development of type 1 diabetes in non-obese diabetic Scid mice
D Chen, D Kakabadse, S Fishman… - Frontiers in …, 2023 - pubmed.ncbi.nlm.nih.gov
Introduction In this study, we report a novel therapeutic approach using B lymphocytes to
attract islet-specific T cells in the non-obese diabetic (NOD) mouse model and prevent the …
attract islet-specific T cells in the non-obese diabetic (NOD) mouse model and prevent the …
Novel engineered B lymphocytes targeting islet-specific T cells inhibit the development of type 1 diabetes in non-obese diabetic Scid mice.
D Chen, D Kakabadse, S Fishman… - Frontiers in …, 2023 - europepmc.org
Methods Purified splenic B cells were treated with lipopolysaccharide, which increases
regulatory B (Breg) cell function, then electroporated with mRNA encoding either chimeric …
regulatory B (Breg) cell function, then electroporated with mRNA encoding either chimeric …